Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G Stake Amended Statement of Ownership
  3. 8-K Event Other events
  4. 424B5 Offering Prospectus
  5. 424B5 Offering Prospectus
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 8-K Event Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 8-K Event Material agreement
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. DEF 14A Proxy Proxy Statement
  17. 4 Insider Changes in Ownership
  18. PRE 14A Proxy Proxy Statement (Preliminary)
  19. CT ORDER Other Confidential Order
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 32 of 41 · 809 filings